This article incorporates text available under the CC BY 4.0 license. Betts, J Gordon; Desaix, Peter; Johnson, Eddie; Johnson, Jody E; Korol, Oksana; Kruse, Dean; Poe, Brandon; Wise, James; Womble, Mark D; Young, Kelly A (2023). "§18.5 Homeostasis". Anatomy & Physiology. Houston: OpenStax CNX. ISBN978-1-947172-04-3.
Gordon, S. G.; Mielicki, W. P. (March 1997). "Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue". Blood Coagulation & Fibrinolysis. 8 (2): 73–86. doi:10.1097/00001721-199703000-00001. ISSN0957-5235. PMID9518049.
Watson, Steve (April 2009). "Platelet Activation by Extracellular Matrix Proteins in Haemostasis and Thrombosis". Current Pharmaceutical Design. 15 (12): 1358–72. doi:10.2174/138161209787846702. PMID19355974.
Ruff CT, Patel SM, Giugliano RP, Morrow DA, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Spinar J, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Parkar S, Bloomfield D, Sabatine MS (January 2025). "Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation". The New England Journal of Medicine. 392 (4): 361–71. doi:10.1056/NEJMoa2406674. PMID39842011.
Rasmussen KL, Philips M, Tripodi A, Goetze JP (June 2020). "Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review". Eur J Haematol. 104 (6): 519–25. doi:10.1111/ejh.13394. PMID32049377.
Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F (February 2021). "Standardization of Prothrombin Time/International Normalized Ratio (PT/INR)". Int J Lab Hematol. 43 (1): 21–28. doi:10.1111/ijlh.13349. PMID32979036.
Demoy M, Labrousse J, Grand F, Moyrand S, Tuffigo M, Lamarche S, Macchi L (June 2024). "[Factor XI deficiency: actuality and review of the literature]". Annales de Biologie Clinique (in French). 82 (2): 225–36. doi:10.1684/abc.2024.1884. PMID38702892.
Schmidt A (1872). "Neue Untersuchungen über die Faserstoffgerinnung". Pflügers Archiv für die gesamte Physiologie. 6: 413–538. doi:10.1007/BF01612263. S2CID37273997.
Shapiro SS (October 2003). "Treating thrombosis in the 21st century". The New England Journal of Medicine. 349 (18): 1762–64. doi:10.1056/NEJMe038152. PMID14585945.
Gordon, S. G.; Mielicki, W. P. (March 1997). "Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue". Blood Coagulation & Fibrinolysis. 8 (2): 73–86. doi:10.1097/00001721-199703000-00001. ISSN0957-5235. PMID9518049.
Watson, Steve (April 2009). "Platelet Activation by Extracellular Matrix Proteins in Haemostasis and Thrombosis". Current Pharmaceutical Design. 15 (12): 1358–72. doi:10.2174/138161209787846702. PMID19355974.
Ruff CT, Patel SM, Giugliano RP, Morrow DA, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Spinar J, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Parkar S, Bloomfield D, Sabatine MS (January 2025). "Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation". The New England Journal of Medicine. 392 (4): 361–71. doi:10.1056/NEJMoa2406674. PMID39842011.
Rasmussen KL, Philips M, Tripodi A, Goetze JP (June 2020). "Unexpected, isolated activated partial thromboplastin time prolongation: A practical mini-review". Eur J Haematol. 104 (6): 519–25. doi:10.1111/ejh.13394. PMID32049377.
Dorgalaleh A, Favaloro EJ, Bahraini M, Rad F (February 2021). "Standardization of Prothrombin Time/International Normalized Ratio (PT/INR)". Int J Lab Hematol. 43 (1): 21–28. doi:10.1111/ijlh.13349. PMID32979036.
Demoy M, Labrousse J, Grand F, Moyrand S, Tuffigo M, Lamarche S, Macchi L (June 2024). "[Factor XI deficiency: actuality and review of the literature]". Annales de Biologie Clinique (in French). 82 (2): 225–36. doi:10.1684/abc.2024.1884. PMID38702892.
Shapiro SS (October 2003). "Treating thrombosis in the 21st century". The New England Journal of Medicine. 349 (18): 1762–64. doi:10.1056/NEJMe038152. PMID14585945.
This article incorporates text available under the CC BY 4.0 license. Betts, J Gordon; Desaix, Peter; Johnson, Eddie; Johnson, Jody E; Korol, Oksana; Kruse, Dean; Poe, Brandon; Wise, James; Womble, Mark D; Young, Kelly A (2023). "§18.5 Homeostasis". Anatomy & Physiology. Houston: OpenStax CNX. ISBN978-1-947172-04-3.
Mayer, Gene (2011). "Ch. 1. Innate (non-specific) immunity". Immunology. Immunology Section of Microbiology and Immunology On-line. University of South Carolina. Archived from the original on 21 October 2014.
Schmidt A (1872). "Neue Untersuchungen über die Faserstoffgerinnung". Pflügers Archiv für die gesamte Physiologie. 6: 413–538. doi:10.1007/BF01612263. S2CID37273997.
"Coagulation Factor". Clotbase.bicnirrh.res.in. Archived from the original on 11 December 2016. Retrieved 20 May 2018.
Mayer, Gene (2011). "Ch. 1. Innate (non-specific) immunity". Immunology. Immunology Section of Microbiology and Immunology On-line. University of South Carolina. Archived from the original on 21 October 2014.
Schmaier, Alvin H.; Lazarus, Hillard M. (2011). Concise guide to hematology. Chichester, West Sussex, UK: Wiley-Blackwell. p.91. ISBN978-1-4051-9666-6. OCLC779160978.
Gordon, S. G.; Mielicki, W. P. (March 1997). "Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue". Blood Coagulation & Fibrinolysis. 8 (2): 73–86. doi:10.1097/00001721-199703000-00001. ISSN0957-5235. PMID9518049.
Hoffbrand, A. V.; Pettit, J. E; Moss, P. A. H. (2002). Essential Haematology (4thed.). London: Blackwell Science. pp.241–43. ISBN978-0-632-05153-3. OCLC898998816.